Review



optum® de-identified electronic health record dataset (optum® ehr)  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Optum Inc optum® de-identified electronic health record dataset (optum® ehr)
    Optum® De Identified Electronic Health Record Dataset (Optum® Ehr), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum++de+identified+electronic+health+record+dataset/pm40664765-68-37-42
    Average 90 stars, based on 1 article reviews
    optum® de-identified electronic health record dataset (optum® ehr) - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: P-1555. Impact of Empiric Treatment Failure on Clinical Outcomes and Healthcare Resource Utilization Among US Females with Uncomplicated Urinary Tract Infections
    Article Snippet: This study used retrospective data from Optum’s de-identified Electronic Health Record (EHR) dataset (Jan 2017 to Sep 2022).

    Article Title: Clinical prediction models for medication adverse events in patients with rheumatic and musculoskeletal conditions: A systematic literature review.
    Article Snippet: Databases included in the study with data mapped to the OMOP CDM, Estonian Health Information System (Estonia); IBM MarketScan® Commercial Database (CCAE); IBM MarketScan® Medicare Supplemental Database (MDCR); IBM MarketScan® MultiState Medicaid Database (MDCD); Integrated Primary Care Information (IPCI); IQVIA Australia EMR (IQVIA Australia); IQVIA Disease Analyser Germany EMR (IQVIA Germany); IQVIA Hospital US Charge Master (IQVIA US Hospital); IQVIA LPD France (IQVIA LPD France); IQVIA UK THIN IMRD EMR (IQVIA THIN); IQVIA US Ambulatory EMR (IQVIA US Ambulatory); Japan Medical Data Center (JMDC); Optum® De-Identified Clinformatics® Data Mart Database (Optum Claims); Optum® De-identified Electronic Health Record Dataset (Optum EHR); The Information System for Research in Primary Care (SIDIAP-H); Optum AMGA EHR, Collaboration of Optum and the American Medical Group Association (AMGA).

    Derivative Assay:

    Article Title: Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study
    Article Snippet: .. Optum® de-identified Electronic Health Record dataset (Optum® EHR) USA, general 108 2007-2023 Combined claims and electronic health record data derived from >7000 hospitals and >7000 clinics. ..



    Similar Products

    optum® de-identified electronic health record dataset (optum® ehr)  (Optum Inc)
    90
    Optum Inc optum® de-identified electronic health record dataset (optum® ehr)
    Optum® De Identified Electronic Health Record Dataset (Optum® Ehr), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum++de+identified+electronic+health+record+dataset/pm40664765-68-37-42
    Average 90 stars, based on 1 article reviews
    optum® de-identified electronic health record dataset (optum® ehr) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    de-identified electronic health record dataset optum® ehr  (Optum Inc)
    90
    Optum Inc de-identified electronic health record dataset optum® ehr
    De Identified Electronic Health Record Dataset Optum® Ehr, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum++de+identified+electronic+health+record+dataset/pmc11836508__mmc1-40-2-6
    Average 90 stars, based on 1 article reviews
    de-identified electronic health record dataset optum® ehr - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    de-identified electronic health record dataset (optum ehr)  (Optum Inc)
    90
    Optum Inc de-identified electronic health record dataset (optum ehr)
    De Identified Electronic Health Record Dataset (Optum Ehr), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/de+identified+electronic+health+record+dataset/pmc11737733-194-75-79
    Average 90 stars, based on 1 article reviews
    de-identified electronic health record dataset (optum ehr) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    de-identified electronic health record dataset optum ehr  (Optum Inc)
    90
    Optum Inc de-identified electronic health record dataset optum ehr
    Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for IBD primary analysis Key: Amb EMR = IQVIA Ambulatory <t>Electronic</t> Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; IBD = irritable bowel diseases (Crohn’s disease or ulcerative colitis); IBD comparator = golimumab, certolizumab pegol, ustekinumab, or vedolizumab; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; Remicade ® (m) = Remicade ® exposure; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)
    De Identified Electronic Health Record Dataset Optum Ehr, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum++de+identified+electronic+health+record+dataset/pmc11681708-92-7-11
    Average 90 stars, based on 1 article reviews
    de-identified electronic health record dataset optum ehr - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    electronic health record dataset (optum ehr)  (Optum Inc)
    90
    Optum Inc electronic health record dataset (optum ehr)
    Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for IBD primary analysis Key: Amb EMR = IQVIA Ambulatory <t>Electronic</t> Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; IBD = irritable bowel diseases (Crohn’s disease or ulcerative colitis); IBD comparator = golimumab, certolizumab pegol, ustekinumab, or vedolizumab; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; Remicade ® (m) = Remicade ® exposure; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)
    Electronic Health Record Dataset (Optum Ehr), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/electronic+health+record+dataset/pm38501749-30-8-12
    Average 90 stars, based on 1 article reviews
    electronic health record dataset (optum ehr) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    optum® de-identified electronic health record (ehr) dataset  (Optum Inc)
    90
    Optum Inc optum® de-identified electronic health record (ehr) dataset
    Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for IBD primary analysis Key: Amb EMR = IQVIA Ambulatory <t>Electronic</t> Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; IBD = irritable bowel diseases (Crohn’s disease or ulcerative colitis); IBD comparator = golimumab, certolizumab pegol, ustekinumab, or vedolizumab; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; Remicade ® (m) = Remicade ® exposure; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)
    Optum® De Identified Electronic Health Record (Ehr) Dataset, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/electronic+health+record+dataset+(optum+ehr)/optum++de+identified+electronic+health+record+dataset/pm38583036-3-38-37
    Average 90 stars, based on 1 article reviews
    optum® de-identified electronic health record (ehr) dataset - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for IBD primary analysis Key: Amb EMR = IQVIA Ambulatory Electronic Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; IBD = irritable bowel diseases (Crohn’s disease or ulcerative colitis); IBD comparator = golimumab, certolizumab pegol, ustekinumab, or vedolizumab; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; Remicade ® (m) = Remicade ® exposure; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)

    Journal: BMC Medical Research Methodology

    Article Title: The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade ®

    doi: 10.1186/s12874-024-02428-7

    Figure Lengend Snippet: Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for IBD primary analysis Key: Amb EMR = IQVIA Ambulatory Electronic Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; IBD = irritable bowel diseases (Crohn’s disease or ulcerative colitis); IBD comparator = golimumab, certolizumab pegol, ustekinumab, or vedolizumab; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; Remicade ® (m) = Remicade ® exposure; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)

    Article Snippet: The EHR databases included Optum ® de-identified Electronic Health Record Dataset (Optum ® EHR) and IQVIA Ambulatory EMR (Amb EMR).

    Techniques:

    Attrition diagrams for inflammatory bowel diseases (IBD); patient attrition counts and proportions after sequential design choices applied Key: Amb EMR = IQVIA Ambulatory Electronic Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; RA = rheumatoid arthritis; RA comparator = certolizumab pegol or tocilizumab; Remicade ® (m) = Remicade ® exposure with concurrent methotrexate; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)

    Journal: BMC Medical Research Methodology

    Article Title: The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade ®

    doi: 10.1186/s12874-024-02428-7

    Figure Lengend Snippet: Attrition diagrams for inflammatory bowel diseases (IBD); patient attrition counts and proportions after sequential design choices applied Key: Amb EMR = IQVIA Ambulatory Electronic Medical Records; ASMD = absolute standardized mean difference; CCAE = Merative™ MarketScan ® Commercial Database; CI = Confidence Interval; Clinformatics ® = Optum ® De-Identified Clinformatics ® Data Mart Database; EASE = expected absolute systematic error; HR = Hazard ratio; Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data; RA = rheumatoid arthritis; RA comparator = certolizumab pegol or tocilizumab; Remicade ® (m) = Remicade ® exposure with concurrent methotrexate; Target covariate prevalence = prevalence of baseline covariates in the initial Remicade ® exposure cohort before study design restrictions were applied; Analytic covariate prevalence = prevalence of baseline covariates in Remicade ® exposure cohort after study design restrictions were applied (i.e., PS matching)

    Article Snippet: The EHR databases included Optum ® de-identified Electronic Health Record Dataset (Optum ® EHR) and IQVIA Ambulatory EMR (Amb EMR).

    Techniques:

    Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for RA primary analysis Key – Target: patients with inflammatory bowel diseases newly exposed to Remicade ® , Comparator: patients with inflammatory bowel diseases newly exposed to [golimumab, certolizumab pegol, ustekinumab, or vedolizumab], CCAE: Merative™ MarketScan ® Commercial Database, Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data

    Journal: BMC Medical Research Methodology

    Article Title: The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade ®

    doi: 10.1186/s12874-024-02428-7

    Figure Lengend Snippet: Empirical equipoise, covariate balance, empirical calibration validity diagnostics and representativeness for RA primary analysis Key – Target: patients with inflammatory bowel diseases newly exposed to Remicade ® , Comparator: patients with inflammatory bowel diseases newly exposed to [golimumab, certolizumab pegol, ustekinumab, or vedolizumab], CCAE: Merative™ MarketScan ® Commercial Database, Optum ® EHR = Optum ® De-Identified Electronic Health Record; Pharmetrics = IQVIA Adjudicated Health Plan Claims Data

    Article Snippet: The EHR databases included Optum ® de-identified Electronic Health Record Dataset (Optum ® EHR) and IQVIA Ambulatory EMR (Amb EMR).

    Techniques:

    Risk of non-infectious uveitis (NIU) among patients with inflammatory bowel diseases (IBD) Key – PS: propensity score, OT: on-treatment, ITT: intention-to-treat, T: Remicade ® new users with IBD, C: golimumab, certolizumab pegol, ustekinumab, or vedolizumab new users with IBD, IR: incidence rate, PYs: person-years, CCAE: Merative™ MarketScan ® Commercial Database, Optum ® EHR: Optum ® De-Identified Electronic Health Record, Pharmetrics: IQVIA Adjudicated Health Plan Claims Data

    Journal: BMC Medical Research Methodology

    Article Title: The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade ®

    doi: 10.1186/s12874-024-02428-7

    Figure Lengend Snippet: Risk of non-infectious uveitis (NIU) among patients with inflammatory bowel diseases (IBD) Key – PS: propensity score, OT: on-treatment, ITT: intention-to-treat, T: Remicade ® new users with IBD, C: golimumab, certolizumab pegol, ustekinumab, or vedolizumab new users with IBD, IR: incidence rate, PYs: person-years, CCAE: Merative™ MarketScan ® Commercial Database, Optum ® EHR: Optum ® De-Identified Electronic Health Record, Pharmetrics: IQVIA Adjudicated Health Plan Claims Data

    Article Snippet: The EHR databases included Optum ® de-identified Electronic Health Record Dataset (Optum ® EHR) and IQVIA Ambulatory EMR (Amb EMR).

    Techniques: